Purdue University
West Lafayette, Indiana, 17907, United States
Location status: Recruiting
Location contact
Richard D Mattes, PhD
CONTACT
Richard D Mattes, PhD, RD, MPH
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06339879
This study will assess the effects of eating whole grain foods versus refined grain foods with different amounts of added sugar. It is hypothesized that a diet including grain products will have beneficial effects on taste hedonics, appetite, food/energy intake, body weight, blood pressure, acute and chronic glycemia and acute and chronic lipemia compared to customary diets controlling for added sugars, saturated fats and sodium.
Interested in participating?
Request Info21 year–60 year
All sexes
Interventional
Not applicable
West Lafayette, Indiana, 17907, United States
Location status: Recruiting
Richard D Mattes, PhD
CONTACT
Richard D Mattes, PhD, RD, MPH
PRINCIPAL_INVESTIGATOR
This 16-week, randomized, controlled, parallel-arm, clinical trial will assess the effects of consuming four different categories of grain foods on taste hedonics, appetite, food/energy intake, body weight, and blood pressure as well as acute and longer-term glycemia and lipemia. It will also examine the effects of foods varying in grain/carbohydrate composition on the microbiome and microbiota functionality. One hundred and twenty adults will be recruited and randomly assigned to one of four intervention groups. These groups will be defined by the diets they are prescribed. All will be prescribed diets containing approximately 50%; 35% and 15% energy from carbohydrate, fat and protein, respectively. Grain foods will comprise 50% of the carbohydrate component (i.e., 25% of total energy). The grain foods will be assigned to one of four categories based on whole grain content and concentrations of added sugars. The grain foods meeting these criteria will have the following composition:
Group 1 - High Whole Grain, Low Sugar 6 servings of whole grain and <13% energy from added sugars.
Group 2 - Low Whole Grain, Low Sugar 3 servings of whole grain and <13% energy from added sugars.
Group 3 - High Whole Grain, High Sugar 6 servings of whole grain and >13% energy from added sugars.
Group 4 - Low Whole Grain, High Sugar 3 servings of whole grain and >13% energy from added sugars.
Detailed Study Design
The study measures and timing are outlined in the following table:
Screening Week 1 Baseline Week 2 Week 5 Week 8 Week 11 Week 14 Fasting Blood X X X XX MTT X X X Weight X X X X X X Body Composition X X CGM X X X Intake X Hedonics (palatability) X X X Appetite X X X Activity X X X Blood Pressure X X X X X X Microbiota X X X X X Compliance X X X X X MTT = Meal Tolerance Test; DXA= Dual-energy X-ray Absorptiometry; CGM=Continuous glucose monitoring
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
6 servings of whole grain and <13% energy from added sugars.
3 servings of whole grain and <13% energy from added sugars.
6 servings of whole grain and >13% energy from added sugars.
3 servings of whole grain and >13% energy from added sugars.
Time frame: 12 weeks
blood sugar
Time frame: 12 weeks
ingestive sensations measured by VAS ratings scale 1 (lowest) - 100 (highest)
Time frame: 12 weeks
palatability
Time frame: 12 weeks
kcals
Time frame: 12 weeks
pounds
Time frame: 12 weeks
mm mercury
Time frame: 12 weeks
Blood lipids
Contact information is provided by the study sponsor or research team.
Judy George, BS
CONTACT
Richard Mattes, PhD
CONTACT
Purdue University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01761955
Body Weight, Dyslipidemias
Winnipeg, Manitoba, Canada
View Trial DetailsNCT01047280
Body Composition, Body Weight
View Trial DetailsNCT00123214
Body Weight, Body Weight Changes
New York, United States
View Trial DetailsNCT07481305
Behavior, Body Weight
Worcester, Massachusetts, United States
View Trial Details